EC authorizes brentuximab vedotin for CTCLJanuary 23, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Ofatumumab to be pulled from non-US marketsJanuary 23, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Drug’s label updated to include risk of allergic reactionsJanuary 17, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
FDA expands approval for arsenic trioxideJanuary 16, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Generic bortezomib available in USJanuary 13, 2018Lymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Drug receives fast track, orphan designations for PTCLDecember 27, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
FDA grants orphan designation to drug for AMLDecember 27, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML